Tuesday, October 1, 2024
Home Business Elon Musk’s Neuralink looks for three patients for long term brain implant study

Elon Musk’s Neuralink looks for three patients for long term brain implant study

by
0 comment

Elon Musk’s Neuralink, a brain-chip company, aims to enroll three patients to evaluate its device in a study expected to take several years to complete, according to a Reuters report which cited details from the US government’s clinical trials database.

Neuralink's logo and Elon Musk's photo are seen in this illustration.(Reuters)
Neuralink’s logo and Elon Musk’s photo are seen in this illustration.(Reuters)

The company is testing its implant designed to give paralyzed patients the ability to use digital devices by thinking alone, a prospect that could help people with spinal cord injuries, according to the report.

Unlock exclusive access to the latest news on India’s general elections, only on the HT App. Download Now! Download Now!

Also Read | Elon Musk’s Neuralink to embed wires deeper in brain after problems in first patient?

The study uses a robot to surgically place a brain-computer interface (BCI) implant in a region of the brain that controls the intention to move, Neuralink had said.

However, Neuralink has for years fielded calls from interested patients, well before the company received approval last year to begin conducting trials in people, Neuralink sources told Reuters.

In January, Neuralink implanted the device in the brain of its first patient, Noland Arbaugh, who is paralyzed from the shoulders down due to a 2016 diving accident, which allowed Arbaugh to play video games, browse the internet and move a computer cursor on his laptop by thinking alone, according to company blog posts and videos.

Also Read | Neuralink’s first human patient Noland Arbaugh told parents he could become handicapped: ‘Didn’t want them to…’

According to eligibility criteria posted on the clinical trials database, patients must have limited mobility without improvement for at least one year, with a life expectancy greater than or equal to 12 months.

Neuralink’s study is estimated to have a primary completion date of 2026, with the full study expected to be complete in 2031. The study will enroll patients between the ages of 22 and 75 years with conditions such as quadriplegia, the report read.

Elevate your career with VIT’s MBA programme that has been designed by its acclaimed faculty & stands out as a beacon for working professionals. Explore now!

Discover the complete story of India’s general elections on our exclusive Elections Product! Access all the content absolutely free on the HT App. Download now!
Get latest news on Education along with Board Exam, Competitive Exam and Exam Result at Hindustan Times. Also get latest Job updates on Employment News

  • ABOUT THE AUTHOR
    author-default-90x90

    Follow the latest breaking news and developments from India and around the world with Hindustan Times’ newsdesk. From politics and policies to the economy and the environment, from local issues to national events and global affairs, we’ve got you covered.

You may also like

Leave a Comment

About Us

Welcome to Janashakti.News, your trusted source for breaking news, insightful analysis, and captivating stories from around the globe. Whether you’re seeking updates on politics, technology, sports, entertainment, or beyond, we deliver timely and reliable coverage to keep you informed and engaged.

@2024 – All Right Reserved – Janashakti.news